Less invasive parotid tumor surgery may reduce nerve damage risk
NCT ID NCT07185542
First seen Jun 24, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This completed trial compared two surgical techniques for removing benign parotid gland tumors: the standard superficial parotidectomy and a newer, less invasive intracapsular parotidectomy. The study involved 120 adults aged 20-65 with confirmed benign tumors. The goal was to see if the less invasive approach could reduce complications like facial nerve damage while still preventing tumor recurrence.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- surgical procedure
- What this could lead to
- If successful, this could show that a less invasive surgery for benign parotid tumors reduces complications like facial nerve damage while still effectively removing the tumor.
- What could go wrong
- This is a single completed trial with 120 participants, so results may not apply to all patients. The less invasive approach may have a higher risk of tumor recurrence.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
120 people
The number who actually took part.
- Started
-
May 2024
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * age between 20 and 65 years, * radiologically and clinically confirmed benign parotid tumor * tumor confined to the superficial or deep lobe without evidence of facial nerve involvement. Exclusion Criteria: * suspicion of malignancy based on imaging or fine-needle aspiration cytology (FNAC) * recurrent parotid tumors * previous parotid surgery * facial nerve dysfunction preoperatively * comorbidities precluding surgery.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign parotid tumor are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Al-Azhar university
Madīnat an Naşr, Cairo Governorate, 4450113, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.